NCT03290378View on ClinicalTrials.gov

Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

409

Participants

Timeline

Start Date

September 19, 2017

Primary Completion Date

April 11, 2018

Study Completion Date

April 23, 2018

Conditions
Pain Management
Interventions
DRUG

Tramadol

IV; 25 mg or 50 mg, given at Hours 0, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44

OTHER

Placebo

IV; Placebo, given at Hours 0, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44

Trial Locations (5)

21122

Cheseapeake Research Group, LLC, Pasadena

77004

H.D. Research Corporation, Houston

78229

Endeavor Clinical Trials, PA, San Antonio

91105

Lotus Clinical Research, Pasadena

93301

Trovare Clinical Research, Bakersfield

Sponsors
All Listed Sponsors
lead

Avenue Therapeutics, Inc.

INDUSTRY

NCT03290378 - Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy | Biotech Hunter | Biotech Hunter